NEODOXy: Targeting Breast Cancer Stem Cells With Doxycycline

NCT06452394 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
50
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Swiss Cancer Institute